The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Research Progress on the Relationship between Atherosclerosis and Inflammation
Open accessAbstract
Atherosclerosis is a chronic inflammatory disease; unstable atherosclerotic plaque rupture, vascular stenosis, or occlusion caused by platelet aggregation and thrombosis lead to acute cardiovascular disease. Atherosclerosis-related inflammation is mediated by proinflammatory cytokines, inflammatory signaling pathways, bioactive lipids, and adhesion molecules. This review discusses the effects of inflammation and the systemic inflammatory signaling pathway on atherosclerosis, the role of related signaling pathways in inflammation, the formation of atherosclerosis plaques, and the prospects of treating atherosclerosis by inhibiting inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,558
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Virmani, R., Kolodgie, F. D., Burke, A. P., Finn, A. V., Gold, H. K., Tulenko, T. N., Wrenn, S. P., & Narula, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000178991.71605.18 · Cited by 1,331
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
Shimoda, K., van Deursent, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., et al. (1996) · Nature · doi:10.1038/380630a0 · Cited by 1,278
C-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150
Ban, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S.-S., Drucker, D. J., & Husain, M. (2008) · Circulation · doi:10.1161/circulationaha.107.739938 · Cited by 1,057 · cited 1×
“Glucagon-like peptide-1 contributes to glucose homeostasis by stimulating insulin secretion in pancreatic β cells, and also exerts cardioprotective and vasodilatory actions [74,75].”
BackgroundRecent insights into the cellular biology of atherosclerosis
Tabas, I., García-Cardeña, G., & Owens, G. K. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412052 · Cited by 1,016 · cited 1×
“In early-stage atherosclerosis, the causes of atherosclerosis are endothelial injury, abnormal lipid metabolism, and hemodynamic damage; and the atherogenic process is considered to be accompanied by flow-mediated inflammatory changes in endothelial cells (ECs) [5].”
BackgroundImmune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 876
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824 · cited 1×
“Glucagon-like peptide-1 contributes to glucose homeostasis by stimulating insulin secretion in pancreatic β cells, and also exerts cardioprotective and vasodilatory actions [74,75].”
BackgroundInflammation and plaque vulnerability
Hansson, G. K., Libby, P., & Tabas, I. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 805
Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6
Jones, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3463 · Cited by 771
LOX-1, OxLDL, and Atherosclerosis
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Mediators of Inflammation · doi:10.1155/2013/152786 · Cited by 769
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730 · cited 1×
“Interleukin-6 is produced by macrophages and T cells during the early stage of the immune response and inflammation, and has proinflammatory properties [80].”
BackgroundAikawa, M., Rabkin, E., Sugiyama, S., Voglic, S. J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F. J., & Libby, P. (2001) · Circulation · doi:10.1161/01.cir.103.2.276 · Cited by 588
Hajra, L., Evans, A. I., Chen, M., Hyduk, S. J., Collins, T., & Cybulsky, M. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9052 · Cited by 574
Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J. W., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18730 · Cited by 573
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 530 · cited 1×
“Therefore, PLA2 inhibitors need to be studied in clinical trials [73].”
BackgroundChang, M.-K., Binder, C. J., Torzewski, M., & Witztum, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192399699 · Cited by 521
Immune mechanisms in atherosclerosis.
Hansson, G. K., Jonasson, L., Seifert, P. S., & Stemme, S. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.567 · Cited by 515
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?
Schönbeck, U., & Libby, P. (2004) · Circulation · doi:10.1161/01.cir.0000129505.34151.23 · Cited by 498
Yvan-Charvet, L., Welch, C., Pagler, T. A., Ranalletta, M., Lamkanfi, M., Han, S., Ishibashi, M., Li, R., Wang, N., & Tall, A. R. (2008) · Circulation · doi:10.1161/circulationaha.108.793869 · Cited by 439
Macrophage Diversity and Polarization in Atherosclerosis: A Question of Balance
Mantovani, A., Garlanda, C., & Locati, M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.180497 · Cited by 426
Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis
Li, Y., Zhong, X., Cheng, G., Zhao, C., Zhang, L., Hong, Y., Wan, Q., He, R., & Wang, Z. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.02.003 · Cited by 418
Self-citationCellular adhesion molecules and atherogenesis
Price, D. T., & Loscalzo, J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00153-9 · Cited by 388
Wilensky, R. L., Shi, Y., Mohler, E. R., Hamamdzic, D., Burgert, M. E., Li, J., Postle, A., Fenning, R. S., Bollinger, J. G., Hoffman, B. E., et al. (2008) · Nature Medicine · doi:10.1038/nm.1870 · Cited by 387
Johnson, J. L., George, S. J., Newby, A. C., & Jackson, C. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506201102 · Cited by 352
Integrins in mechanotransduction
Ross, T. D., Coon, B. G., Yun, S., Baeyens, N., Tanaka, K., Ouyang, M., & Schwartz, M. A. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.05.006 · Cited by 341
Kanters, E., Pasparakis, M., Gijbels, M. J. J., Vergouwe, M. N., Partouns-Hendriks, I., Fijneman, R. J. A., Clausen, B. E., Förster, I., Kockx, M. M., Rajewsky, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18580 · Cited by 340
Rosenfeld, M. E., & Ross, R. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.5.680 · Cited by 331
McInnes, I. B., Thompson, L., Giles, J. T., Bathon, J. M., Salmon, J. E., Beaulieu, A. D., Codding, C. E., Carlson, T. H., Delles, C., Lee, J. S., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204345 · Cited by 324
C-Reactive Protein in Atherothrombosis and Angiogenesis
Badimon, L., Peña, E., Arderiu, G., Padró, T., Slevin, M., Vilahur, G., & Chiva-Blanch, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00430 · Cited by 323
Kanter, J. E., Kramer, F., Barnhart, S., Averill, M. M., Vivekanandan-Giri, A., Vickery, T., Li, L. O., Becker, L., Yuan, W., Chait, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111600109 · Cited by 309
Calabro, P., Chang, D. W., Willerson, J. T., & Yeh, E. T. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.017 · Cited by 308
Luttun, A., Lutgens, E., Manderveld, A., Maris, K., Collen, D., Carmeliet, P., & Moons, L. (2004) · Circulation · doi:10.1161/01.cir.0000121728.14930.de · Cited by 308
A new modality for immunosuppression: targeting the JAK/STAT pathway
O'Shea, J. J., Pesu, M., Borie, D. C., & Changelian, P. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1441 · Cited by 303
Peterson, J. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00029-8 · Cited by 298
Held, C., White, H. D., Stewart, R. A. H., Budaj, A., Cannon, C. P., Hochman, J. S., Koenig, W., Siegbahn, A., Steg, P. G., Soffer, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005077 · Cited by 291
Psychosocial Factors and Inflammation in the Multi-Ethnic Study of Atherosclerosis
Ranjit, N. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.2.174 · Cited by 260
Nagashima, M., Watanabe, T., Terasaki, M., Tomoyasu, M., Nohtomi, K., Kim-Kaneyama, J., Miyazaki, A., & Hirano, T. (2011) · Diabetologia · doi:10.1007/s00125-011-2241-2 · Cited by 259 · cited 1×
“Glucagon-like peptide-1 with its receptor (GLP-1R) suppress exudate peritoneal macrophage foam cell formation induced by oxLDL [76].”
BackgroundDeguchi, J.-O., Aikawa, E., Libby, P., Vachon, J. R., Inada, M., Krane, S. M., Whittaker, P., & Aikawa, M. (2005) · Circulation · doi:10.1161/circulationaha.105.562041 · Cited by 224
Effect of MMP-2 Deficiency on Atherosclerotic Lesion Formation in ApoE-Deficient Mice
Kuzuya, M., Nakamura, K., Sasaki, T., Wu Cheng, X., Itohara, S., & Iguchi, A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000218496.60097.e0 · Cited by 202
Toll-Like Receptor 4 Is Involved in Outward Arterial Remodeling
Hollestelle, S. C. G., de Vries, M. R., van Keulen, J. K., Schoneveld, A. H., Vink, A., Strijder, C. F., van Middelaar, B. J., Pasterkamp, G., Quax, P. H. A., & de Kleijn, D. P. V. (2004) · Circulation · doi:10.1161/01.cir.0000109140.51366.72 · Cited by 197
Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans
Cipollone, F., Mezzetti, A., Fazia, M. L., Cuccurullo, C., Iezzi, A., Ucchino, S., Spigonardo, F., Bucci, M., Cuccurullo, F., Prescott, S. M., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000172632.96987.2d · Cited by 173
Kaartinen, M., Penttilä, A., & Kovanen, P. T. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.6.966 · Cited by 173
Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability
Johnson, J. L. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.2.265 · Cited by 172
Johnson, J. L., Baker, A. H., Oka, K., Chan, L., Newby, A. C., Jackson, C. L., & George, S. J. (2006) · Circulation · doi:10.1161/circulationaha.106.613281 · Cited by 170
Potential of anti-inflammatory agents for treatment of atherosclerosis
Chistiakov, D. A., Melnichenko, A. A., Grechko, A. V., Myasoedova, V. A., & Orekhov, A. N. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.01.008 · Cited by 165
Integrin signaling in atherosclerosis
Finney, A. C., Stokes, K. Y., Pattillo, C. B., & Orr, A. W. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2490-4 · Cited by 157
Tashiro, Y., Sato, K., Watanabe, T., Nohtomi, K., Terasaki, M., Nagashima, M., & Hirano, T. (2014) · Peptides · doi:10.1016/j.peptides.2013.12.015 · Cited by 149
Recinos, A., LeJeune, W. S., Sun, H., Lee, C. Y., Tieu, B. C., Lu, M., Hou, T., Boldogh, I. R., Tilton, R. G., & Brasier, A. R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.013 · Cited by 135
JANUS under stress—Role of JAK/STAT signaling pathway in vascular diseases
Grote, K., Luchtefeld, M., & Schieffer, B. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.08.021 · Cited by 128
Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis
Ortiz-Muñoz, G., Martín-Ventura, J. L., Hernández-Vargas, P., Mallavia, B., López-Parra, V., López‐Franco, Ó., Muñoz‐García, B., Fernández‐Vizarra, P., Ortega, L. M., Egido, J., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.173781 · Cited by 125
C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth
Molins, B., Peña, E., Vilahur, G., Mendieta, C., SLEVIN, M. A., & Badimón, L. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.174359 · Cited by 121
Fotis, L., Agrogiannis, G., Vlachos, I. S., Pantopoulou, A., Margoni, A., Kostaki, M., Verikokos, C., Tzivras, D. M., Mikhailidis, D. P., & Perrea, D. N. (2012) · PubMed · Cited by 120
Leukocyte adhesion and thrombosis
Afshar‐Kharghan, V., & Thiagarajan, P. (2005) · Current Opinion in Hematology · doi:10.1097/01.moh.0000190107.54790.de · Cited by 113
Blaha, M. J., Rivera, J. J., Budoff, M. J., Blankstein, R., Agatston, A. A., O’Leary, D. H., Cushman, M., Gilchrist, S. C., Criqui, M. H., Szklo, M., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.223768 · Cited by 111
Inflammation may be a bridge connecting hypertension and atherosclerosis
Li, J., & Chen, J. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.10.016 · Cited by 103
Interferons as Essential Modulators of Atherosclerosis
Boshuizen, M. C. S., & de Winther, M. P. J. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305464 · Cited by 97
Rosenson, R. S., Hislop, C., Elliott, M. D., Stasiv, Y., Goulder, M. A., & Waters, D. D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.015 · Cited by 95
Complement factor H binds to denatured rather than to native pentameric C-reactive protein
Hakobyan, S., Harris, C. L., van den Berg, C. W., Fernandez-Alonso, M. C., de Jorge, E. G., de Cordoba, S. R., Rivas, G., Mangione, P., Pepys, M. B., & Morgan, B. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803648200 · Cited by 90
Effect of interleukin 1β inhibition in cardiovascular disease
Qamar, A., & Rader, D. J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328359b0a6 · Cited by 87
Simvastatin modulates TNFα-induced adhesion molecules expression in human endothelial cells
Zapolska‐Downar, D., Siennicka, A., Kaczmarczyk, M., Kołodziej, B., & Naruszewicz, M. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.03.005 · Cited by 86
Madan, M., Bishayi, B., Hoge, M., & Amar, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.02.023 · Cited by 86
Abbate, A., Tassell, B. W. V., & Biondi‐Zoccai, G. (2012) · BioDrugs · doi:10.1007/bf03261881 · Cited by 84
Vidal, C., Gómez‐Hernández, A., Sánchez-Galán, E., González, A., Ortega, L. M., Gómez-Gerique, J. A., Tuñón, J., & Egido, J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110361 · Cited by 78
Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression
Zeng, X., Guo, R., Dong, M., Zheng, J., Lin, H., & Lu, H. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1479-6 · Cited by 66
Alaarg, A., Senders, M. L., Varela-Moreira, A., Pérez‐Medina, C., Zhao, Y., Tang, J., Fay, F., Reiner, T., Fayad, Z. A., Hennink, W. E., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.013 · Cited by 61
Konstantino, Y., Nguyen, T. T., Wolk, R. A., Aiello, R. J., Terra, S. G., & Fryburg, D. A. (2009) · Biomarkers · doi:10.1080/13547500902765140 · Cited by 51
Aker, S., Bantis, C., Reis, P., Kuhr, N., Schwandt, C., Grabensee, B., Heering, P., & Ivens, K. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp141 · Cited by 49
Mechanisms of Myeloid Cell Modulation of Atherosclerosis
Świrski, F. K., Nahrendorf, M., & Libby, P. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0026-2015 · Cited by 48
Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium.
Zhou, M., Qin, S., Chu, Y., Wang, F., Chen, L., & Lu, Y. (2014) · PubMed Central · Cited by 46
TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target
Liu, Y., Yu, H., Zhang, Y., & Zhao, Y. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.05.030 · Cited by 40
Gwon, W., Joung, E., Kwon, M., Lim, S.-J., Utsuki, T., & Kim, H. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.11.014 · Cited by 40
Cao, X., Zhang, L., Chen, C., Wang, Q., Guo, L., Ma, Q., Deng, P., Zhu, G., Li, B., ., Y. P., et al. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2518-3 · Cited by 34
Choi, J., Jeon, H. J., Park, J., Sonn, S. K., Lee, M., Lee, M.-N., You, H. J., Kim, G., Kim, J., Lee, M.-H., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.003 · Cited by 18
Rašić, S., Rebić, D., Hasić, S., Rašić, I., & Delić-Šarac, M. (2015) · Mediators of Inflammation · doi:10.1155/2015/614357 · Cited by 16
Alaarg, A., Zheng, K. H., van der Valk, F. M., da Silva, A. E., Versloot, M., van Ufford, L. Q., Schulte, D. M., Storm, G., Metselaar, J. M., Stroes, E. S. G., et al. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.04.006 · Cited by 12
Detection of a large deletion in the P-selectin (SELP) gene
Pasquali, A., Trabetti, E., Romanelli, M. G., Galavotti, R., Martinelli, N., Girelli, D., Gambaro, G., Olivieri, O., & Pignatti, P. F. (2009) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2009.11.006 · Cited by 9
Cited by
Bai, J., Zhang, Y., Tang, C., Hou, Y., Ai, X., Chen, X., Zhang, Y., Wang, X., & Meng, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110985 · Cited by 720
Macrophage polarization: an important role in inflammatory diseases
Luo, M., Zhao, F., Cheng, H., Su, M., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352946 · Cited by 468
Insulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 385
CCL5/CCR5 axis in human diseases and related treatments
Zeng, Z., Lan, T., Wei, Y., & Wei, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.004 · Cited by 378
The role of CD36 in cardiovascular disease
Shu, H., Peng, Y., Hang, W., Nie, J., Zhou, N., & Wang, D. W. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvaa319 · Cited by 277
Metadata
- Authors
- Zhu, Y., Xian, X., Wang, Z., Bi, Y., Chen, Q., Han, X., Tang, D., & Chen, R.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2018-08-23
- Volume
- 8
- Issue
- 3
- Pages
- 80
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W2888679536
- Cited by
- 872
- References
- 85
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.